Galderma adds new president, general manager of North American business

FORT WORTH, Texas — Galderma Labs on Monday announced that it had promoted Miles Harrison to be president and general manager of Galderma’s North American branch, heading up its U.S. and Canada teams.  

 

“Galderma is experiencing a tremendous amount of growth following the launch of eight new products across all three business units in the U.S. over the past 18 months,” Galderma PharStuart Raetzman, Chief Executive Officer of Galderma Pharma S.A.  “Miles has the vision and experience to lead our organization at this exciting time of rapid and sustainable growth.”

 

Harrison joined Galderma U.S. in 2014 from Novartis as VP and general manager, self-medication business unit, which includes Cetaphil. During his tenure in that position, the division has launched several new products, including Excipal Skin Solutions, as well as men and baby lines of Cetaphil. Galderma’s North American operations are centered around three units: self-medication business, aesthetic and corrections and the prescription business, which includes the company’s Epiduo Gel and Epiduo Forte Gel.

 

“I am honored to take this leadership position at a time when Galderma is experiencing such fantastic growth and transformation,” Harrison said. "I am proud to be part of a company consistently trusted by doctors and patients that is truly changing people's lives with its solutions for skin health. We are committed to meeting the dermatological needs of people throughout their lives and we will continue to deliver innovative medical solutions to healthcare professionals, patients and consumers."